Use of cidofovir in pediatric patients with adenovirus infection [version 1; referees: 2 approved]
Background: Adenoviruses contribute to morbidity and mortality among immunocompromised pediatric patients including stem cell and solid organ transplant recipients. Cidofovir (CDV), an antiviral compound approved by the FDA in 1996, is used for treatment of adenoviral (ADV) infections in immunocompr...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2016-04-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/5-758/v1 |